Company performance
Add to research
Current Price
as of Apr 22, 2025$278.40
P/E Ratio
36.82
Market Cap
$149.68B
Loading...
Description
Add to research
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Metrics
Add to research
Overview
- HQThousand Oaks, CA
- SectorHealth Technology
- IndustryBiotechnology
- TickerAMGN
- Price$278.4+1.72%
Trading Information
- Market cap$149.68B
- Float99.77%
- Average Daily Volume (1m)3,164,124
- Average Daily Volume (3m)3,217,434
- EPS$7.62
Company
- Revenue$33.23B
- Rev growth (1yr)18.64%
- Net income$4.09B
- Gross margin64.19%
- EBITDA margin41.84%
- EBITDA$13.91B
- EV$189.91B
- EV/Revenue5.71
- P/E36.82
- P/S4.53
- P/B25.43
- Debt/Equity1,035.89
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset